Chembio Shares Owned by Institutions

CEMI
 Stock
  

USD 0.86  0.01  1.18%   

Chembio Diagnostics fundamentals help investors to digest information that contributes to Chembio Diagnostics' financial success or failures. It also enables traders to predict the movement of Chembio Stock. The fundamental analysis module provides a way to measure Chembio Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chembio Diagnostics stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Chembio Shares Owned by Institutions Analysis

Chembio Diagnostics' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
 2019 2020 2021 2022 (projected)
Revenues USD34.46 M32.47 M47.82 M41.89 M
Revenues34.46 M32.47 M47.82 M41.89 M
Shares Held by Institutions 
 = 
Funds and Banks 
Firms 
More About Shares Owned by Institutions | All Equity Analysis

Current Chembio Diagnostics Shares Owned by Institutions

    
  9.34 %  
Most of Chembio Diagnostics' fundamental indicators, such as Shares Owned by Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chembio Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Chembio Shares Owned by Institutions Driver Correlations

Understanding the fundamental principles of building solid financial models for Chembio Diagnostics is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Shares Owned by Institutions. Since Chembio Diagnostics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chembio Diagnostics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chembio Diagnostics' interrelated accounts and indicators.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Compare to competition

Based on the latest financial disclosure, 9.34% of Chembio Diagnostics are shares owned by institutions. This is 79.08% lower than that of the Healthcare sector and 82.64% lower than that of the Diagnostics & Research industry. The shares owned by institutions for all United States stocks is 76.18% higher than that of the company.

Chembio Shares Owned by Institutions Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chembio Diagnostics' direct or indirect competition against its Shares Owned by Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chembio Diagnostics could also be used in its relative valuation, which is a method of valuing Chembio Diagnostics by comparing valuation metrics of similar companies.
Chembio Diagnostics is currently under evaluation in shares owned by institutions category among related companies.

Chembio Diagnostics Current Valuation Drivers

We derive many important indicators used in calculating different scores of Chembio Diagnostics from analyzing Chembio Diagnostics' financial statements. These drivers represent accounts that assess Chembio Diagnostics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chembio Diagnostics' important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee(38.62 K)(26.66 K)(42.21 K)(71.69 K)(100.6 K)(103.25 K)
Revenue Per Employee145.55 K113.25 K106.37 K91.22 K141.9 K153.21 K
Average Assets19.09 M31.75 M50.08 M66.01 M66.07 M53.11 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(5.18 M)(7.08 M)(11.41 M)(20.44 M)(28.12 M)(28.86 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(5.18 M)(7.08 M)(11.41 M)(20.44 M)(28.12 M)(28.86 M)
Earnings before Tax(6.46 M)(7.93 M)(14.18 M)(25.98 M)(33.97 M)(34.86 M)
Average Equity15.2 M24.7 M27.21 M29.65 M30.14 M27.5 M
Enterprise Value99.24 M90.84 M83.16 M92.61 M24.17 M24.81 M
Free Cash Flow(6.06 M)(13.25 M)(12.56 M)(22.85 M)(32.71 M)(33.57 M)
Invested Capital6.56 M13.38 M46.81 M45.26 M52.03 M56.14 M
Invested Capital Average8.74 M10.77 M38.03 M45.9 M52.23 M56.36 M
Market Capitalization101.01 M97.28 M80.1 M95.84 M34.25 M53.56 M
Tangible Asset Value13.35 M32.04 M45.94 M55.28 M70.23 M75.77 M
Working Capital7.76 M21.93 M25.78 M27.39 M39.95 M43.1 M

Chembio Diagnostics Institutional Holders

Institutional Holdings refers to the ownership stake in Chembio Diagnostics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chembio Diagnostics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chembio Diagnostics' value.
Security TypeSharesValue
Royce Associates LpCommon Shares135.8 K88 K
Valmark Advisers IncCommon Shares51.4 K33 K
Signaturefd LlcCommon Shares35 K23 K
Group One Trading LpCall Options25 K16 K
Hightower Advisors LlcCommon Shares21 K14 K
Newbridge Financial Services Group IncCommon Shares20.4 K13 K
Group One Trading LpCommon Shares19.1 K12 K
Simplex Trading LlcCommon Shares15.7 K10 K
Simplex Trading LlcPut Options15.7 K10 K

Chembio Fundamentals

About Chembio Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Chembio Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chembio Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chembio Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care diagnostic tests that are used to detect or diagnose diseases. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York. Chembio Diagnostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 337 people.

Chembio Diagnostics Investors Sentiment

The influence of Chembio Diagnostics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Chembio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Chembio Diagnostics Implied Volatility

    
  97.99  
Chembio Diagnostics' implied volatility exposes the market's sentiment of Chembio Diagnostics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chembio Diagnostics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chembio Diagnostics stock will not fluctuate a lot when Chembio Diagnostics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chembio Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chembio Diagnostics' short interest history, or implied volatility extrapolated from Chembio Diagnostics options trading.

Pair Trading with Chembio Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chembio Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chembio Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Chembio Diagnostics

0.71AXDXAccelerate Diagnosti Earnings Call  TomorrowPairCorr

Moving against Chembio Diagnostics

0.57ABVCAbvc Biopharma Earnings Call  TomorrowPairCorr
0.55GTHGenetron Holdings Earnings Call  Next WeekPairCorr
0.54ABCAmerisourcebergen Corp Fiscal Year End 3rd of November 2022 PairCorr
The ability to find closely correlated positions to Chembio Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chembio Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chembio Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chembio Diagnostics to buy it.
The correlation of Chembio Diagnostics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chembio Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chembio Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chembio Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Chembio Diagnostics Piotroski F Score and Chembio Diagnostics Altman Z Score analysis. Note that the Chembio Diagnostics information on this page should be used as a complementary analysis to other Chembio Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Chembio Stock analysis

When running Chembio Diagnostics price analysis, check to measure Chembio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chembio Diagnostics is operating at the current time. Most of Chembio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Chembio Diagnostics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chembio Diagnostics' price. Additionally, you may evaluate how the addition of Chembio Diagnostics to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Is Chembio Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chembio Diagnostics. If investors know Chembio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chembio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
26 M
Quarterly Revenue Growth YOY
0.42
Return On Assets
-0.3
Return On Equity
-2.06
The market value of Chembio Diagnostics is measured differently than its book value, which is the value of Chembio that is recorded on the company's balance sheet. Investors also form their own opinion of Chembio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Chembio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chembio Diagnostics' market value can be influenced by many factors that don't directly affect Chembio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chembio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine Chembio Diagnostics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chembio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.